All News

Subpart 58-1 of Title 10 of the New York State Codes, Rules and Regulations (NYCRR) was amended, and new Subpart 58-6 was adopted on September 2, 2026.

On July 15, 2026, Dr. Sherry Faye, Director of the Wadsworth Center’s Nuclear Chemistry Laboratory (NCL), served as an invited guest speaker at the U.S. Department of Energy and American Chemical Society-sponsored Nuclear Chemistry Summer School (NCSS) at Brookhaven National Laboratory.  This highly selective six-week program is designed to introduce undergraduate students to graduate programs and careers in nuclear science.  Dr. Faye presented an overview of the NCL’s mission and capabilities, including

Dr. Joseph Orsini, Deputy Director of the New York State Newborn Screening Program at the Wadsworth Center, co-authored the Association of Public Health Laboratories’ Metachromatic Leukodystrophy Toolkit.  The resource supports public health programs considering implementation of newborn screening for metachromatic leukodystrophy (MLD).  The toolkit provides an overview of MLD and the newborn-screening process, practical implementation guidance, and educational materials for physicians who follow up with families after a positive screen. Dr.

Every year many hospitalizations and deaths in the U.S. result from serious infections caused by bacteria resistant to a powerful group of antibiotics called carbapenems.To fight these dangerous infections, the Centers for Disease Control and Prevention (CDC) has created guidelines that focus on: 

These newborn screening annual reports are provided for informational use only, and should not be used for research purposes. Because of the way the report is constructed, the values for individual conditions are subject to change. Please contact the program for up-to-date information.

The Wadsworth Center’s Laboratory of Viral Diseases has identified an emergent echovirus 17 (E17) genotype affecting communities in the Mid-Atlantic region and New York City. The cluster was detected through enhanced enterovirus surveillance initiated following identification of the 2022 poliovirus case. More than 40 E17 cases have been identified, primarily among neonates younger than 30 days.

A recent study coauthored by a Wadsworth Center scientist suggests that following U.S. dietary guidelines during pregnancy may reduce exposure to some, but not all, environmental chemicals. The study, published in the American Journal of Clinical Nutrition, examined how diet quality relates to chemical exposures among pregnant participants in the National Institutes of Health-funded Environmental influences on Child Health Outcomes (ECHO) Program.

Research led by Dr. Nilesh Banavali and colleagues at the Wadsworth Center has been selected...

The New York State was the first state to initiate newborn screening for Krabbe disease thanks to the Newborn Screening Program at the Wadsworth Center. Krabbe disease is a rare and often fatal leukodystrophy affecting the white matter of the brain and the central and peripheral nervous systems. 

Dr. Kurunthachalam Kannan of the Wadsworth Center’s Division of Environmental Health Sciences (DEHS) serves on the working group of the International Agency for Research on Cancer (IARC) to evaluate the carcinogenicity of butyl benzyl phthalate (BBzP), dibutyl phthalate (DBP), and diisononyl phthalate (DINP). 

Drs. Anil Ojha and Pallavi Ghosh of the Wadsworth Center’s Division of Genetics attended the Microbial Stress Response Gordon Research Conference at Mount Holyoke College in South Hadley, Massachusetts. Dr. Ojha presented research on ribosome hibernation in mycobacteria, a process that can promote the persistence of Mycobacterium tuberculosis during antibiotic treatment. Dr. Ghosh presented her work on sigma factor D responses and rifampicin resistance in Mycobacterium abscessus.

Dr. Siân Owen, a Principal Investigator and Research Scientist at the Wadsworth Center, has been awarded a highly competitive five-year, $1.97 million Maximizing Investigators' Research Award (MIRA) from the National Institutes of Health's National Institute of General Medical Sciences.

Dr. Kurunthachalam Kannan of the Wadsworth Center’s Division of Environmental Health Sciences delivered a keynote lecture at the Trans-NIH Workshop on Micro- and Nanoplastic Measurement for Population Studies, held at the National Cancer Institute’s Shady Grove campus in Maryland on July 9-10, 2026. Dr.

Dr. Thomas Bartlett attended the 2026 conference for the American Society of Microbiology’s premier annual meeting held in Washington, DC, from June 3-7.

The Wadsworth Center’s Newborn Screening Program hosted a specialized national training workshop at the David Axelrod Institute in Albany from June 10-12, 2026, providing laboratory and follow-up professionals from newborn screening programs across the United States with training on five disorders recently added to the federal Recommended Uniform Screening Panel (RUSP): Krabbe disease, guanidinoacetate methyltransferase (GAMT) deficiency, mucopolysaccharidosis type II (MPS II), Duchenne muscular dystrophy (DMD), and metachromatic leukodystrophy (MLD).

The Wadsworth Center Bacteriology Laboratory, in collaboration with the New York State Department of Health Bureau of Communicable Disease Control (BCDC), the Bureau of Community Environmental Health and Food Protection, and the Broome County Department of Public Health, is assisting in the investigation of a large foodborne outbreak of Salmonella enterica associated with the Broome County Correctional Facility.

Dr. Jiada Li of the Wadsworth Center’s Bioinformatics Core attended the 90th Cold Spring Harbor Laboratory Symposium on Quantitative Biology, AI in Biology, held in Cold Spring Harbor, New York, from May 26-31, 2026. During the symposium, Dr. Li presented a poster titled “Leveraging a Fine-Tuned Vision Foundation Model for Precise Mycobacterial Cell Segmentation and Fluorescence Event Classification in Multi-Channel Time-Lapse Microscopy Images.” The work, co-authored with Tayler Farrington, Dr. Spencer Bruce, and Dr.

Dr. Patrick Parsons, Director of the Division of Environmental Health Sciences at the Wadsworth Center, presented recent advances in human mercury biomonitoring at the XXIV Brazilian Congress of Toxicology (CBTOX 2026), held in São Paulo, Brazil, from June 3-6, 2026.

Dr. Carlos Saavedra-Matiz and Dr. Denise Kay of the Wadsworth Center’s Newborn Screening Program participated in the 2026 Newborn Screening Molecular Training Workshop, co-sponsored by the Association of Public Health Laboratories (APHL) and the Centers for Disease Control and Prevention (CDC). The workshop was held in Atlanta, Georgia, from June 1-5, 2026.

Dr. Kimberlee Musser of the Wadsworth Center’s Division of Infectious Diseases was invited to attend the Antimicrobial Resistance (AR) Laboratory Network Central Region Laboratory In-Person Meeting in St. Paul, Minnesota, June 10-12, as a cross-regional representative of the Northeast AR Laboratory Network. Dr. Musser delivered a presentation and contributed to discussions throughout the meeting, drawing on 10 years of experience supporting the Wadsworth Center’s role in the Northeast Regional AR Laboratory Network.